We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Gut “Memory” May Explain Why IBD Flares Return

By LabMedica International staff writers
Posted on 28 Aug 2026

Inflammatory bowel diseases (IBD), including Crohn’s disease and ulcerative colitis, are characterized by recurring flare-ups that damage the intestinal mucosa and remain difficult to predict. More...

Although acute intestinal injury often precedes these conditions, the mechanisms that transform temporary damage into chronic inflammation are not fully understood. Clinicians also lack reliable markers to determine whether apparently healed tissue remains at risk. New findings show that lasting changes in the gut’s extracellular matrix can encode an inflammatory “memory” that alters stem cell fate long after symptoms have subsided.

Researchers at the Weizmann Institute of Science investigated whether short-lived intestinal inflammation leaves lasting imprints in the extracellular matrix (ECM), the protein-sugar scaffold surrounding epithelial cells. In mouse models of acute colitis, they tracked tissue architecture and ECM properties for more than a year after clinical recovery. The team also used miniature three-dimensional intestinal organoids grown from stem cells, along with single-cell RNA sequencing (scRNA-seq) resources and seven biopsies from patients with ulcerative colitis, to probe how ECM alterations influence epithelial differentiation.

The study identified collagen 18 as a key mediator of this inflammatory imprint. According to the authors, collagen 18 can trap signaling molecules within the ECM, disrupting pathways that normally direct stem cells to rebuild healthy epithelium and instead biasing them toward pro-inflammatory epithelial states. Silencing collagen 18 expression in mice prevented the ECM from sustaining irreversible damage and halted progression to chronic disease, supporting a causal role for ECM remodeling in persistent inflammation.

Even after the animals appeared to recover, the ECM remained less stiff, more porous, and disorganized at 80 and 400 days, revealing a long-lasting “memory” within the tissue microenvironment. Organoids grown on the disrupted ECM formed malformed sheets rather than normal crypt–villus structures, while transcriptomic profiling showed that the cells matured into inflammation-promoting epithelial states that recruit immune cells.

Published August 26, 2026, in Immunity, the findings suggest that the ECM acts as a “logistics hub” that stores and regulates signaling cues, with potential implications for predicting flare-prone regions and identifying therapeutic targets such as collagen 18.

“Growing stem cells as organoids within a disrupted extracellular matrix was enough to change their fate. Using a single-cell RNA sequencing database and seven biopsies from patients with ulcerative colitis, we found that these same pro-inflammatory epithelial cells also characterize inflamed regions in patients. These findings make it clear that the extracellular matrix plays a critical role in chronic inflammation and could potentially make it possible to predict which regions will develop inflammation or experience a future flare-up. More broadly, the new study reveals just how central the ECM is in creating a microenvironment, or niche, that supports stem cell regeneration,” said Dr. Moshe Biton of the Weizmann Institute of Science.

Related Links
Weizmann Institute of Science

 


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
POC Immunoassay Analyzer
Procise DX
Thyroid Test
Anti-Thyroid EIA Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The screening algorithm incorporates two plasma biomarkers: amyloid-beta ratio and p-tau217, which together help indicate brain amyloid burden (Image Credit: Shutterstock)

Algorithm Uses Blood Biomarkers to Improve Alzheimer’s Trial Screening

Alzheimer’s disease is a progressive neurodegenerative disorder that causes memory loss and functional decline. Screening cognitively healthy adults for prevention trials is slow and costly because many... Read more

Microbiology

view channel
Image: The current BDBV outbreak in the DRC underscores response challenges for rare, severe infections (Image Credit: 123RF)

Research Strengthens Bundibugyo Virus Outbreak Readiness with Faster Diagnostics

Bundibugyo virus (BDBV), a species of ebolavirus, causes severe hemorrhagic disease and can be difficult to diagnose rapidly during outbreaks. Recent regulatory changes have further complicated swift deployment... Read more

Technology

view channel
Image: The 5811 R retains the performance and versatility of its predecessor while adding a new design, a refreshed user interface, and updated sustainable cooling technology. (Photo courtesy of Eppendorf)

New Multipurpose Centrifuge Combines High Capacity with Sustainable Cooling

Laboratories often need centrifugation that accommodates multiple vessel formats while maintaining controlled temperatures to protect sensitive samples. Intuitive controls and repeatable operation can... Read more

Industry

view channel
Image: The combined offering is designed to streamline workflows and support multicolor applications used in leukemia, lymphoma, and measurable residual disease assessment in specialized clinical settings

Sysmex and Cytek Collaboration Expands Access to Advanced Clinical Flow Cytometry

Sysmex Europe SE (Hamburg, Germany) and Cytek Biosciences (Fremont, CA, USA) are partnering across more than a dozen European countries to expand access to advanced clinical flow cytometry.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.